Institutional investors hold a majority ownership of AMGN through the 83.35% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2014, these large investors purchased a net $6.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB ... Bought 1.3 Million shares of Amgen Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 992.9 Thousand shares of Amgen Inc
STRALEM & CO., INC. Bought 326.2 Thousand shares of Amgen Inc